Journal
PHARMACOLOGICAL REPORTS
Volume 61, Issue 4, Pages 595-603Publisher
SPRINGER HEIDELBERG
DOI: 10.1016/S1734-1140(09)70111-2
Keywords
NF-kappa B; diabetes; diabetic cardiomyopathy; diabetic retinopathy; diabetic nephropathy; diabetic neuropathy
Categories
Ask authors/readers for more resources
The nuclear factor-kappa B (NF-kappa B) family is comprised of DNA-binding protein factors that are required for the transcription of most proinflammatory molecules, including adhesion molecules, enzymes, cytokines, and chemokines. Studies performed in a variety of cell and animal based experimental systems suggest that NF-kappa B activation is a key event early in the pathobiology of diabetes. The purpose of this review is to summarize the current knowledge about the molecular biology of NF-kappa B and to review evidence that implicates NF-kappa B in the pathogenesis of diabetes and its associated complications.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available